FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket
Shares of GCL Global Holdings Ltd GCL rose sharply in today’s pre-market trading. GCL and RF Acquisition Corp. disclosed the successful completion of their business combination. GCL Global shares ...